ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 120925 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 120925; 2) Community: the network communities that were significantly associated with the response to NSC 120925; 3) Molecule: the relationships between components within communities and NSC 120925; 4) MDR: the compounds that were significantly associated with the NSC 120925.

NSC Compound Enrichment Correlation
NSC 748148 5-iodo-2-{[(2)-3-(2-chlorophenyl)prop-2-enoyl]amino}benzamide 0.0295480456086947 0.28322795
NSC 749245 N-(3-{(2E)-3-[4-(diethylamino)phenyl]prop-2-enoyl}phenyl)methanesulfonamide 0.0295480456086947 0.2665053
NSC 751465 Null 0.0295480456086947 0.23076754
NSC 752892 N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide 0.0295480456086947 0.40347318
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0295480456086947 -0.0064245454
NSC 762009 Copper(II) complex with quin as a ligand 0.0295480456086947 0.28587615
NSC 113951 6-Bromotoyocamycin 0.0314734733353265 0.34640213
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0314734733353267 0.72380938
NSC 150555 Afungin 0.0314734733353267 0.29182046
NSC 606498 Camptothecin Derivative 0.0314734733353267 0.17591368
Total:71  Current:54    [First] [Prev] [Next] [Last]